South Africa will now be paying 40% less for the multidrug-resistant tuberculosis (MDR-TB) drug bedaquiline. Bedaquiline is a key component in the cocktail of drugs used to treat MDR-TB. Pharmaceutical giant Johnson & Johnson (J&J) is currently the sole manufacturer…
Pharmaceutical giant Johnson & Johnson (J&J) recently announced that it would lift patents on the life drug bedaquiline. Bedaquiline is a key component in the cocktail of drugs used to treat multidrug-resistant tuberculosis (MDR-TB) which develops when the TB bacteria…
The world’s largest clinical trial for multidrug-resistant tuberculosis (MDR-TB) has found that the two new shortened treatment regimens are safe and effective. The newly published trial result also indicates lower patient direct costs. The long-awaited results from stage 2 of…
The Global Fund has donated R8.8-billion to South Africa to fight HIV/Aids, tuberculosis, and malaria. The grant, which runs for three years from April 2022 until March 2025, gives a major boost to the country’s efforts to eradicate these diseases.…
World TB Day is observed on 24 March each year. This year’s theme ‘Invest to End TB. Save Lives’ was created with the urgent need to invest in resources to ramp up the fight against the disease. As the world…
People battling rifampicin-resistant tuberculosis (RR-TB) could soon have access to a shorter and safer course of treatment. Doctors without Borders (MSF) have released the results from a clinical trial on an all oral six-month treatment regime. Current treatment can last…
